BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 10898951)

  • 1. CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90.
    Goasduff T; Cederbaum AI
    Arch Biochem Biophys; 2000 Jul; 379(2):321-30. PubMed ID: 10898951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH-dependent microsomal electron transfer increases degradation of CYP2E1 by the proteasome complex: role of reactive oxygen species.
    Goasduff T; Cederbaum AI
    Arch Biochem Biophys; 1999 Oct; 370(2):258-70. PubMed ID: 10510285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the proteasome complex in degradation of human CYP2E1 in transfected HepG2 cells.
    Yang MX; Cederbaum AI
    Biochem Biophys Res Commun; 1996 Sep; 226(3):711-6. PubMed ID: 8831679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells.
    Huan JY; Streicher JM; Bleyle LA; Koop DR
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):332-43. PubMed ID: 15364548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular chaperone Hsp90 plays a role in the assembly and maintenance of the 26S proteasome.
    Imai J; Maruya M; Yashiroda H; Yahara I; Tanaka K
    EMBO J; 2003 Jul; 22(14):3557-67. PubMed ID: 12853471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geldanamycin-induced destabilization of Raf-1 involves the proteasome.
    Schulte TW; An WG; Neckers LM
    Biochem Biophys Res Commun; 1997 Oct; 239(3):655-9. PubMed ID: 9367823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts.
    Nimmanapalli R; O'Bryan E; Bhalla K
    Cancer Res; 2001 Mar; 61(5):1799-804. PubMed ID: 11280726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molybdate inhibits hsp90, induces structural changes in its C-terminal domain, and alters its interactions with substrates.
    Hartson SD; Thulasiraman V; Huang W; Whitesell L; Matts RL
    Biochemistry; 1999 Mar; 38(12):3837-49. PubMed ID: 10090774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors.
    Kamal A; Thao L; Sensintaffar J; Zhang L; Boehm MF; Fritz LC; Burrows FJ
    Nature; 2003 Sep; 425(6956):407-10. PubMed ID: 14508491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of geldanamycin on the kinetics of chaperone-mediated renaturation of firefly luciferase in rabbit reticulocyte lysate.
    Thulasiraman V; Matts RL
    Biochemistry; 1996 Oct; 35(41):13443-50. PubMed ID: 8873613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome.
    Loo MA; Jensen TJ; Cui L; Hou Y; Chang XB; Riordan JR
    EMBO J; 1998 Dec; 17(23):6879-87. PubMed ID: 9843494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct regulation of insulin receptor substrate-1 and -2 by 90-kDa heat-shock protein in adrenal chromaffin cells.
    Yoshikawa N; Nemoto T; Satoh S; Maruta T; Yanagita T; Chosa E; Wada A
    Neurochem Int; 2010 Jan; 56(1):42-50. PubMed ID: 19737590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geldanamycin-induced PCNA degradation in isolated Hsp90 complex from cancer cells.
    Wang X; Heuvelman DM; Carroll JA; Dufield DR; Masferrer JL
    Cancer Invest; 2010 Jul; 28(6):635-41. PubMed ID: 20394503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo.
    Whitesell L; Sutphin P; An WG; Schulte T; Blagosklonny MV; Neckers L
    Oncogene; 1997 Jun; 14(23):2809-16. PubMed ID: 9190897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-independent association between SV40 large T antigen and the major cytosolic heat shock protein, HSP90.
    Miyata Y; Yahara I
    Oncogene; 2000 Mar; 19(11):1477-84. PubMed ID: 10723140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association.
    Nagata Y; Anan T; Yoshida T; Mizukami T; Taya Y; Fujiwara T; Kato H; Saya H; Nakao M
    Oncogene; 1999 Oct; 18(44):6037-49. PubMed ID: 10557093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium dodecyl sulfate (SDS) activation of the 20S proteasome in rat liver.
    Shibatani T; Ward WF
    Arch Biochem Biophys; 1995 Aug; 321(1):160-6. PubMed ID: 7639516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibition of three peptidase activities of the proteasome in human lens epithelium by heat and oxidation.
    Andersson M; Sjöstrand J; Karlsson JO
    Exp Eye Res; 1999 Jul; 69(1):129-38. PubMed ID: 10375457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent association of isolated bovine lens multicatalytic proteinase complex (proteasome) with heat-shock protein 90, an endogenous inhibitor.
    Wagner BJ; Margolis JW
    Arch Biochem Biophys; 1995 Nov; 323(2):455-62. PubMed ID: 7487111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome.
    An WG; Schulte TW; Neckers LM
    Cell Growth Differ; 2000 Jul; 11(7):355-60. PubMed ID: 10939589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.